2023
DOI: 10.1016/j.prp.2023.154880
|View full text |Cite
|
Sign up to set email alerts
|

The role of miRNAs in multiple sclerosis pathogenesis, diagnosis, and therapeutic resistance

Ahmed S. Doghish,
Ola Elazazy,
Hend H. Mohamed
et al.
Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
2
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 12 publications
(3 citation statements)
references
References 276 publications
0
2
0
Order By: Relevance
“…One of the newest challenges regarding ncRNAs is represented by circRNAs. Even though they are the newest discovered ncRNAs involved in MS pathogenesis [11], they have not been extensively explored, and they further need to be studied in the context of the molecular pathways they are possibly involved in [159]. This issue is not just related to circRNAs; it also involves miRNAs and lcnRNAs.…”
Section: Future Perspectivesmentioning
confidence: 99%
“…One of the newest challenges regarding ncRNAs is represented by circRNAs. Even though they are the newest discovered ncRNAs involved in MS pathogenesis [11], they have not been extensively explored, and they further need to be studied in the context of the molecular pathways they are possibly involved in [159]. This issue is not just related to circRNAs; it also involves miRNAs and lcnRNAs.…”
Section: Future Perspectivesmentioning
confidence: 99%
“…miRNA profiling and technical aspects regarding the isolation procedure of the same is not clearly resolved and lacks internal controls. The miRNA agents fail to attribute their stipulated effect in the in vivo scenario 226 . Furthermore, the drug delivery in miRNA therapy is extremely challenging.…”
Section: Conclusion and Future Outlookmentioning
confidence: 99%
“…The miRNA agents fail to attribute their stipulated effect in the in vivo scenario. 226 Furthermore, the drug delivery in miRNA therapy is extremely challenging. The miRNA drug is easily degraded in the first pass metabolism due to the action of nuclease on the miRNA.…”
Section: Conclusion and Future Outlookmentioning
confidence: 99%